Ciladopa hydrochloride

Reactant or reagent for synthesis of: ? Positron emission tomography ligand for imaging metabotropic glutamate receptor type 1 ? Stitching agent for introduction of aziridines into functionalized organic molecules ? Parenteral cephalosporins.

GluN2C/GluN2D-selective NMDA antagonist.

GluN2C/GluN2D-selective NMDA antagonist.

GluN2C/GluN2D-selective NMDA antagonist.

GluN2C/GluN2D-selective NMDA antagonist.

GluN2C/GluN2D-selective NMDA antagonist.

Inhibits Con A-stimulated mitogenesis in murine T cells. Lymphocyte marker in cancer patients.

General DescriptionHydrocinnamaldehyde is C=C double bond hydrogenated cinnamaldehyde. It has been synthesized by the selective hydrogenation of C=C double bond of cinnamaldehyde by various methods. Hydrocinnamaldehyde and nitromethane undergoes

A widely-used non-specific inhibitor of cAMP and cGMP PDEs (IC₅₀ = 19, 50, 18, 13, 32, 7, and 50 &muM for PDE1, PDE2, PDE3, PDE4, PDE5, PDE7, and PDE11, respectively).

A widely-used non-specific inhibitor of cAMP and cGMP PDEs (IC₅₀ = 19, 50, 18, 13, 32, 7, and 50 &muM for PDE1, PDE2, PDE3, PDE4, PDE5, PDE7, and PDE11, respectively).

A widely-used non-specific inhibitor of cAMP and cGMP PDEs (IC₅₀ = 19, 50, 18, 13, 32, 7, and 50 &muM for PDE1, PDE2, PDE3, PDE4, PDE5, PDE7, and PDE11, respectively).

INCB086550 (PD-1/PD-L1-IN-8: example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt:= 10 nM.Form:Solid.